Mammoth
PrivateLast Round
Series D
Sep 9, 2021
Est. Valuation
$1B
Total Funding Raised
$287.6M
Momentum
Quiet
No recent growth signals
Company Overview
Mammoth Biosciences is a biotechnology company focused on developing long-term curative therapies and decentralized precision diagnostics through the use of proprietary ultracompact proteins for advanced in vivo gene editing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mammoth Comps
Public and private peers based on sector, stage, and business model.
Mammoth Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 9, 2021 | ||||
| Series C | Nov 1, 2020 | ||||
| Grant | Jul 30, 2020 | ||||
| Series B | Jan 30, 2020 | ||||
| Series A | Jul 31, 2018 | ||||
Seed | Nov 1, 2017 |
Key People
Founding team and executive leadership
Mammoth Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series D |
| NFX | Series A, Series B, Series D, Seed, Pre Seed |
| Pacific 8 Ventures | Series B |
| NIH RADx | Grant |
| Plum Alley Investments | Series B |
| StepStone Group | Series D |
| Sixth Street Partners | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Preclinical data for MB-111 to be presented at industry congress.
- Oct 1, 2025
Presenting at the European Society of Gene & Cell Therapy Congress.
Mammoth Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mammoth's valuation, stock price, and market status.
